Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PDUFA's 'Real-World' Journey Expected To Be Slow Walk

Executive Summary

Manufacturers are enthusiastic about the possibility of using real-world evidence to expand product indications. But even with new resource support, they know it's a long road to get there.

Advertisement

Related Content

Woodcock's Legacy: CDER Organizational Improvements
2020 Vision For FDA's Sentinel: 'Systemic' Integration Of Surveillance Looms
Diabetes Drug Safety Might Be Best Assessed With Real-World Data
FDA To Join The 'Real World' Under PDUFA VI
FDA's Califf On Real World Evidence: 'Use It For The Right Purposes'

Topics

Advertisement
UsernamePublicRestriction

Register

PS118826

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel